{
  "id": "mhgap#referral_e2c49d17",
  "content": "31. WHO guideline: recommendations on digital\n22. Lewin S, Glenton C, Lawrie TA, Downe S, interventions for health system strengthening:\nFinlayson KW, Rosenbaum S et al. Qualitative evidence and recommendations. Geneva: World\nevidence synthesis (QES) for guidelines: paper Health Organization; 2019 (https://iris.who.int/\n2 – using qualitative evidence synthesis findings handle/10665/311980).\nto inform evidence-to-decision frameworks\n32. Agabio R, Camposeragna A, Saulle R, Krupchanka\nand recommendations. Health Res Policy Syst.\nD, Leggio L, Minozzi S. Combined pharmacological\n2019;17(1):75 (https://doi.org/10.1186/s12961-019-\nand psychosocial interventions for alcohol\n0468-4).\nuse disorder. Cochrane Database Syst Rev.\n2023;(3):CD015673.\n116\nReferences\n33. Chawla N, Anothaisintawee T, 40. Pauley D, Cuijpers P, Papola D, Miguel C, Karyotaki\nCharoenrungrueangchai K, Thaipisuttikul P, E. Two decades of digital interventions for\nMckay GJ, Attia J et al. Drug treatment for panic anxiety disorders: a systematic review and meta-\ndisorder with or without agoraphobia: systematic analysis of treatment effectiveness. Psychol\nreview and network meta-analysis of randomised Med. 2023;53(2):567–79 (https://doi.org/10.1017/\ncontrolled trials. BMJ. 2022;376:e066084 (https:// S0033291721001999).\ndoi.org/10.1136/bmj-2021-066084).\n41. Kim HS, Kim EJ. Effects of relaxation therapy on\n34. Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng anxiety disorders: a systematic review and meta-\nZ, Freemantle N. Pharmacological treatments analysis. Arch Psychiatr Nurs. 2018;32(2):278–84",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "stress",
      "work",
      "coping_skill",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Referral 31. WHO guideline: recommendations on digital\n22. Lewin S, Glenton C, Lawrie TA, Downe S, interventions for health system strengthening:\nFinlayson KW, Rosenbaum S et al. Qualitative evidence and recommendations. Geneva: World\nevidence synthesis (QES) for guidelines: paper Health Organization; 2019 (https://iris.who.int/\n2 – using qualitative evidence synthesis findings handle/10665/311980).\nto inform evidence-to-decision frameworks\n32. Agabio R, Camposeragna A, Saulle R, Krupchanka\nand recommendations. Health Res Policy Syst.\nD, Leggio L, Minozzi S. Combined pharmacological\n2019;17(1):75 (https://doi.org/10.1186/s12961-019-\nand psychosocial interventions for alcohol\n0468-4).\nuse disorder. Cochrane Database Syst Rev.\n2023;(3):CD015673.\n116\nReferences\n33. Chawla N, Anothaisintawee T, 40. Pauley D, Cuijpers P, Papola D, Miguel C, Karyotaki\nCharoenrungrueangchai K, Thaipisuttikul P, E. Two decades of digital interventions for\nMckay GJ, Attia J et al. Drug treatment for panic anxiety disorders: a systematic review and meta-\ndisorder with or without agoraphobia: systematic analysis of treatment effectiveness. Psychol\nreview and network meta-analysis of randomised Med. 2023;53(2):567–79 (https://doi.org/10.1017/\ncontrolled trials. BMJ. 2022;376:e066084 (https:// S0033291721001999).\ndoi.org/10.1136/bmj-2021-066084).\n41. Kim HS, Kim EJ. Effects of relaxation therapy on\n34. Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng anxiety disorders: a systematic review and meta-\nZ, Freemantle N. Pharmacological treatments analysis. Arch Psychiatr Nurs. 2018;32(2):278–84 31. who guideline: recommendations on digital\n22."
}